Autonomix Medical raises $2.6M via warrant exercise inducement; issues new warrants

Autonomix Medical, Inc.

Gross proceeds of ~$2.6M from immediate cash exercise of 428,731 existing Series C warrants at reduced price of $6.00/share.
Issued new Series D-1 and D-2 warrants to purchase up to 428,731 shares each at $5.75/share, exercisable immediately for 5.5 years.
Resale of shares from existing warrants already registered; new warrants unregistered, company to file resale registration statement within 15 days.
Maxim Group acted as warrant inducement agent, receiving 7.0% cash fee plus up to $15,000 expense reimbursement.
Closing expected on or about July 15, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.